CTOs on the Move

T3D Therapeutics

www.t3dtherapeutics.com

 
T3D Therapeutics` mission is to develop its lead drug product candidate, T3D-959, as a potential `First-in-Class`and `Best-in-Class` disease-modifying, breakthrough medicine for the treatment of Alzheimer`s disease with the potential to slow, stop or reverse the course of the disease. The Company is also seeking to maximize the therapeutic utility of T3D=959 and has initiated pre-clinical studies in Huntington’s Disease models.
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.t3dtherapeutics.com
  • 68 T.W. Alexander Drive PO Box 13628
    Research Triangle Park,, NC USA 27709
  • Phone: 919.237.4897

Executives

Name Title Contact Details

Funding

T3D Therapeutics raised $15M on 11/04/2019

Similar Companies

MicroMD

MicroMD is a Youngstown, OH-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Wedgewood Pharmacy

Wedgewood Pharmacy is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Swedesboro, NJ. To find more information about Wedgewood Pharmacy, please visit www.wedgewoodpharmacy.com

Design Clinicals

Design Clinicals is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Tukwila, WA. To find more information about Design Clinicals, please visit www.designclinicals.com

Brownsboro Park Retirement Community

Brownsboro Park Retirement Community is a Louisville, KY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Acadia Pharmaceuticals

Our Acadia family of care-ageous warriors aspire to enable brighter moments for patients and their loved ones. For more than 25 years we have been working at the forefront of healthcare to bring vital solutions to people who need them most. We developed and commercialized the first and only approved therapy for hallucinations and delusions associated with Parkinson`s disease psychosis. Our late-stage development efforts are focused on dementia-related psychosis, negative symptoms of schizophrenia and Rett syndrome. And in early-stage clinical research, we are exploring novel approaches to pain management, cognition and neuropsychiatric symptoms in central nervous system disorders. Important Notice for Candidates - Be Aware of Fraudulent Recruiting Activity Acadia Pharmaceuticals has become aware of fraudulent recruiting activity being circulated via email and LinkedIn by individuals impersonating Acadia Talent Acquisition employees. These communications may appear legitimate due to an official-looking Acadia email address or website, referencing of an actual recruiter and/or manager at Acadia (easily found on LinkedIn), and/or offer documents falsely signed by an Acadia executive. The impostor uses the incentive of a job interview and job offer to solicit sensitive personal information from the intended victim. Please note that the Acadia Talent Acquisition and HR Team will ONLY interact with a candidate from "Acadia-pharm.com" domain sourced emails. We do not request sensitive personal information, such as a Social Security Number, or payments of any kind during the interview or job offer process. Acadia strongly recommends individuals, who receive email solicitations, to carefully verify the authenticity of the correspondence before responding. Never provide personal information or click on links if you are unsure a communication`s legitimacy. If in doubt, please contact talentacquisition@acadia-pharm.com to verify.